These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152 [TBL] [Abstract][Full Text] [Related]
9. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review. Shi Y; Wang E Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689 [TBL] [Abstract][Full Text] [Related]
10. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies. Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248 [TBL] [Abstract][Full Text] [Related]
11. [Clinical Characteristics of CD4 He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088 [TBL] [Abstract][Full Text] [Related]
13. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases]. Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384 [TBL] [Abstract][Full Text] [Related]
14. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review. Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199 [TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm. Zhang X; Wu Y; Li C; Shen K; Li R Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129 [TBL] [Abstract][Full Text] [Related]
16. Clinical and biologic features of CD4(+)CD56(+) malignancies. Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268 [TBL] [Abstract][Full Text] [Related]
17. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148 [TBL] [Abstract][Full Text] [Related]
18. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia. Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444 [TBL] [Abstract][Full Text] [Related]
19. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy. Riaz W; Zhang L; Horna P; Sokol L Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209 [TBL] [Abstract][Full Text] [Related]